Lumify
Active Ingredient(s): Brimonidine TartrateFDA Approved: * December 22, 2017
Pharm Company: * BAUSCH AND LOMB INC
Category: Vision / Eye Health
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Lumify Overview
Brimonidine is a medication used to treat open-angle glaucoma, ocular hypertension, and rosacea.[1][2] In rosacea it improves the redness.[2] It is used as eye drops or applied to the skin.[1][2] Common side effects when used in the eyes include itchiness, redness, and a dry mouth.[1] Common side effects when used on the skin include redness, burning, and headaches.[2] More signific...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Brimonidine
Recent Lumify Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Brimonidine Tartrate
- Drops: 0.2%
- Gel: 0.33%
- Solution: 0.15%, 0.2%
- Solution/drops: 0.025%, 0.1%, 0.10%, 0.15%, 0.2%, 0.20%, 0.5%, 0.50%
Other drugs which contain Brimonidine Tartrate or a similar ingredient: (8 results)
- ALPHAGAN Brimonidine1 discussion
- ALPHAGAN P Brimonidine
- BRIMONIDINE
- MIRVASO Brimonidine
- BRIMONIDINE TARTRATE + TIMOLOL MALEATE
- BRINZOLAMIDE + BRIMONIDINE TARTRATE
- COMBIGAN Brimonidine Tartrate + Timolol Maleate2 discussions
- SIMBRINZA Brinzolamide + Brimonidine Tartrate2 discussions